Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (488) Arrow Down
Filter Results: (488) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (488)
    • People  (1)
    • News  (152)
    • Research  (274)
    • Events  (3)
    • Multimedia  (3)
  • Faculty Publications  (94)

Show Results For

  • All HBS Web  (488)
    • People  (1)
    • News  (152)
    • Research  (274)
    • Events  (3)
    • Multimedia  (3)
  • Faculty Publications  (94)
← Page 8 of 488 Results →
  • 06 Jun 2017
  • First Look

First Look at New Research and Ideas: June 6, 2017

understanding the lack of diversity in entrepreneurship and the venture capital industry. Download working paper: https://www.hbs.edu/faculty/Pages/item.aspx?num=52704 Cellophane, the New Visuality, and the... View Details
Keywords: Sean Silverthorne
  • May 2016 (Revised March 2020)
  • Teaching Note

Cyberdyne: A Leap to the Future

By: Doug J. Chung and Mayuka Yamazaki
Cyberdyne Inc. was a Japanese technology venture founded in 2004 by scientist Yoshiyuki Sankai to commercialize a hybrid assistive limb (HAL). HAL was a robotic exoskeleton system for people who had difficulty walking due to nervous system disabilities resulting from... View Details
Keywords: Health Disorders; Technological Innovation; Marketing Strategy; Decisions; Product Launch; Medical Devices and Supplies Industry
Citation
Purchase
Related
Chung, Doug J., and Mayuka Yamazaki. "Cyberdyne: A Leap to the Future." Harvard Business School Teaching Note 516-114, May 2016. (Revised March 2020.)
  • 23 May 2017
  • First Look

First Look at New Ideas and Research: May 23, 2017

https://www.hbs.edu/faculty/Pages/item.aspx?num=52673 Harvard Business School Case 517-050 Beingmate Founded in 2002, Hangzhou, China–based Beingmate was a major producer of infant formula and related products in the high-demand Chinese... View Details
Keywords: Carmen Nobel
  • 12 Feb 2014
  • News

A decidedly mixed bag

  • 06 Mar 2018
  • First Look

First Look at Research and Ideas, March 6, 2018

https://www.hbs.edu/faculty/Pages/item.aspx?num=52341 February 20, 2018 JAMA, the Journal of the American Medical Association Administrative Costs Associated with Physician Billing and Insurance-Related... View Details
Keywords: Sean Silverthorne
  • 16 Oct 2013
  • Op-Ed

Response to Readers: Combating Climate Change with Nuclear Power and Fracking

With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
Keywords: by Joe Lassiter; Energy; Utilities
  • 08 Jan 2020
  • Research & Ideas

NFL Head Coaches Are Getting Younger. What Can Organizations Learn?

three years of fast food experience. By contrast, Torres continues, incumbent C-level exes are “overly focused on internal issues and opt to invest in familiar technologies rather than taking bold risks.”... View Details
Keywords: by Boris Groysberg, Evan M.S. Hecht, and Abhijit Naik; Sports
  • 24 Apr 2018
  • First Look

First Look at New Research and Ideas, April 24, 2018

April 2018 Management Science Offline Showrooms in Omni-channel Retail: Demand and Operational Benefits By: Bell, David R., Santiago Gallino, and Antonio Moreno Abstract—Omnichannel environments where... View Details
Keywords: Sean Silverthorne
  • 14 Jul 2020
  • Research & Ideas

Restarting Under Uncertainty: Managerial Experiences from Around the World

international cosmetic manufacturer based in France decided to support its 100,000+ clients—salons—across Western Europe to help them survive through the first phases of the COVID-19 crisis. The support included financial, operational, HR, View Details
Keywords: by Raffaella Sadun, Andrea Bertoni, Alexia Delfino, Giovanni Fassio, and Mariapaola Testa
  • 01 Jun 2002
  • News

Up to the Challenge: Lori Schock - Listen and Learn

insists, “it's theirs.” One opinion that was heard loud and clear during Schock's SA service was a call for a new prescription drug plan for HBS students. Schock was among student leaders who met with... View Details
Keywords: Kathleen Brill
  • 14 Dec 2020
  • Research & Ideas

What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?

Number one, understand that this vaccine that's being approved is not like other approved drugs from the US Food and Drug Administration. Usually... View Details
Keywords: by Danielle Kost; Pharmaceutical; Health
  • 30 Oct 2020
  • News

The Pandemic Is Costing Americans More Money Than Official Numbers Suggest

  • 13 Jul 2020
  • Research & Ideas

Merck CEO Ken Frazier Discusses a COVID Cure, Racism, and Why Leaders Need to Walk the Talk

gives away a drug called Mectizan for river blindness. That's one pill per person per year. And we found it's really hard to get that the last mile to the people who really need it. Okay? So I would say... View Details
Keywords: by Staff; Pharmaceutical
  • January 2020
  • Article

The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System

By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz
Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has... View Details
Keywords: Medical Devices; Health Testing and Trials; Analysis; Sales
Citation
Read Now
Related
Monteleone, Peter P., Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, and Mark J. Pirwitz. "The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System." Journal of Invasive Cardiology 32, no. 1 (January 2020).
  • December 2022
  • Article

'Just Letting You Know…': Underestimating Others' Desire for Constructive Feedback

By: Nicole Abi-Esber, Jennifer E. Abel, Juliana Schroeder and Francesca Gino
People often avoid giving feedback to others even when it would help fix a problem immediately. Indeed, in a pilot field study (N=155), only 2.6% of individuals provided feedback to survey administrators that the administrators had food or marker on their faces.... View Details
Keywords: Feedback; Helping; Prosocial Behavior; Misprediction; Relationships; Interpersonal Communication; Perspective
Citation
Find at Harvard
Purchase
Related
Abi-Esber, Nicole, Jennifer E. Abel, Juliana Schroeder, and Francesca Gino. "'Just Letting You Know…': Underestimating Others' Desire for Constructive Feedback." Journal of Personality and Social Psychology 123, no. 6 (December 2022): 1362–1385.
  • Article

Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries

By: Ariel Dora Stern, William J. Gordon, Adam B. Landman and Daniel B. Kramer
Objectives:
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
Keywords: Digital; Medicine; FDA; Health Care and Treatment; Applications and Software; Safety; Cybersecurity; Medical Devices and Supplies Industry
Citation
Read Now
Related
Stern, Ariel Dora, William J. Gordon, Adam B. Landman, and Daniel B. Kramer. "Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries." BMJ Open 9, no. 6 (June 2019).
  • 15 Dec 2015
  • News

The Year in Ideas 2015

to something big. After a second field study, Solomon and Hillerstrom launched NeuroPhage. In tests on mice, the drug they developed improved both memory and cognitive... View Details
Keywords: Julia Hanna, Christine Lejeune, Dan Morrell, and April White
  • January 2016 (Revised July 2018)
  • Case

Cyberdyne: A Leap to the Future

By: Doug J. Chung and Mayuka Yamazaki
Cyberdyne Inc. was a Japanese technology venture that wanted to commercialize a hybrid assistive limb (HAL). HAL was a robotic exoskeleton system for people who had difficulty walking due to nervous system disabilities resulting from stroke, spinal cord injury (SCI),... View Details
Keywords: Go-to-market Strategy; Pricing; Sales Channel; Technological Innovation; Marketing; Sales; Distribution; Strategy; Medical Devices and Supplies Industry
Citation
Educators
Purchase
Related
Chung, Doug J., and Mayuka Yamazaki. "Cyberdyne: A Leap to the Future." Harvard Business School Case 516-072, January 2016. (Revised July 2018.)
  • 08 Nov 2016
  • First Look

November 8, 2016

foods, which had previously been colored with dyes extracted from natural plants and organic minerals, helping them to achieve mass production and mass marketing. Color was easier to control, reproduce,... View Details
Keywords: Sean Silverthorne
  • 01 Sep 2017
  • News

Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up

and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs... View Details
Keywords: April White; Publishing Industries (except Internet); Information
  • ←
  • 8
  • 9
  • …
  • 24
  • 25
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.